{"doi":"10.1111/resp.14624","title":"Adaptation in real time: Wildfire smoke exposure and respiratory health","abstract":"Wildfires are increasing in frequency, intensity and area burned worldwide, fuelled in part by human-caused climate change.1, 2 Wildfire smoke (WFS) plumes, containing a complex mixture of airborne particulates, carbon monoxide and dioxide, nitrogen oxides, volatile organic compounds and other products of combustion, can travel thousands of miles3 and pose a threat to human health far from the site of the responsible fire (Figure 1). Fine particulate matter (PM2.5), a product of combustion processes more generally and present at high concentrations in WFS, is closely linked to health effects. WFS-attributed PM2.5 concentration is a commonly reported metric of WFS exposure, and in WFS-affected areas frequently exceeds recommended World Health Organization targets by more than 20-fold.4 Indeed, in some areas the rise in airborne particulates attributed to WFS has negated up to 50% of western US policy-related improvements in air quality over the last two decades.5 The short-term, negative health impacts of WFS are widely recognized. There is consistent evidence of association between WFS exposure and acute respiratory health outcomes, including respiratory infections, exacerbations of pre-existing asthma and chronic obstructive pulmonary disease, and related healthcare use.6 WFS exposure is also linked to all-cause mortality, and there is growing evidence for cardiovascular7 and other health effects.8 Effects are amplified in susceptible populations, including infants and children, pregnant people, the elderly, and those with pre-existing cardiac or respiratory conditions. Evidence is limited regarding the impact of long-term or repeated WFS exposure, potential delayed health effects, and the role of WFS exposure in the pathogenesis of diseases such as asthma or chronic obstructive pulmonary disease (COPD). Urgent investigation of these questions is warranted, as chronic exposure to PM2.5 from non-WFS pollutant sources has been causally linked to new-onset respiratory and cardiovascular disease, cancer, as well as increased mortality.9 Some evidence suggests that WFS-attributed PM2.5 may have exaggerated health impacts compared to other forms of PM2.5.10, 11 WFS is enriched with fine particles which have a high relative surface area to adsorb toxicants and chemicals.12 These particles can penetrate deep into the lung during respiration and translocate across the alveolar-capillary barrier, carrying adsorbed products directly into the bloodstream. Current data from in vitro, animal and human models suggest that PM2.5 exposure activates inflammation and oxidative stress pathways within the lung and systemically13; whether and how mechanistic pathways may differ by pollutant source, composition and co-pollutants is an area of active investigation. To address health impacts, there is critical need for drastic reduction in global fossil fuel emissions and parallel optimization of forest management. While these objectives are pursued, health interventions aim to limit WFS exposure. Individuals are encouraged to check and respond to their local air quality, primarily via air quality indices released by national public health or environmental agencies and incorporating PM2.5 data from government monitors (such as the US Air Quality Index and Canadian Air Quality Health Index). When air quality is poor based on these indices, remaining indoors is generally recommended, along with decreasing the indoor infiltration of outdoor air, using high efficiency particle air (HEPA) filtration and limiting indoor particle-producing activities (such as burning candles). If individuals are unable to make their own environment safe, or if there are other risks to safety (e.g., from co-exposure to extreme heat) they should ideally relocate either to publicly available spaces with cleaner air or to the home of a relative or friend with access to mitigation measures. During travel, individuals should use vehicle air filtration or N-95 respirators to reduc","journal":"Respirology","year":2023,"id":385641,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9536,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":460758,"name":"Mary E. Crocker","orcid":"0000-0002-0587-1249","position":1,"is_corresponding":false},{"id":313966,"name":"Emily Brigham","orcid":"0000-0002-8449-5420","position":0,"is_corresponding":true}],"reference_count":14,"raw_metadata":null,"created_at":"2026-07-19T01:17:52.636565Z","pmid":"37987098","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}